Principal Display Panel
Cet-label-88 (Cet Label 88)
Cet-label-30 (Cet Label 30)
Cetirizine Hydrochloride Tablet, Coated
FDA Label NDC 62207-764
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Granules India Ltd for the product Cetirizine Hydrochloride (NDC 62207-764). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
* Please review the disclaimer below.
